These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 538557)

  • 1. [Antithrombin II. Immunological and biological levels in hepatic cirrhosis and in disseminated intravascular coagulation (author's transl)].
    Barrantes A; Fonseca JE
    Sangre (Barc); 1979; 24(6):1043-7. PubMed ID: 538557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison between anticoagulant activity and antigenicity of plasma antithrombin III in healthy subjects and patients with disseminated intravascular coagulation (DIC) (author's transl)].
    Matsuda T; Ogawara M; Miura R; Seki T; Yokouchi M; Murakami M; Fujisawa M; Nakanishi K; Nakamura S
    Rinsho Ketsueki; 1980 Mar; 21(3):341-6. PubMed ID: 6157843
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombin III during liver transplantation.
    Lewis JH; Bontempo FA; Ragni MV; Starzl TE
    Transplant Proc; 1989 Jun; 21(3):3543-4. PubMed ID: 2662520
    [No Abstract]   [Full Text] [Related]  

  • 4. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
    Damus PS; Wallace GA
    Thromb Res; 1975 Jan; 6(1):27-38. PubMed ID: 46627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prothrombin abnormality in the case of warfarin treatment, disseminated intravascular congulation syndrome and liver cirrhosis (author's transl)].
    Sakuragawa N
    Rinsho Byori; 1976 Apr; 24(4):279-80. PubMed ID: 945382
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antithrombin III].
    Lagutina NIa; Fedulova GA
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):42-50. PubMed ID: 7045862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombin III assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases.
    Saxena V; Mishra DK; Subramanya H; Satyanarayana S; Sharma A
    Indian J Pathol Microbiol; 2004 Apr; 47(2):210-2. PubMed ID: 16295470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consumption of antithrombin III in plasma (author's transl)].
    Matsuda T
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):597-603. PubMed ID: 696198
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
    Braunstein KM; Eurenius K
    Am J Clin Pathol; 1976 Sep; 66(3):488-94. PubMed ID: 60879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of antithrombin III by sandwich enzymeimmunoassay technique.
    Tanaka M; Kato K
    Thromb Res; 1981 Apr 1-15; 22(1-2):67-74. PubMed ID: 6794177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
    Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
    Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; measurement with new synthetic substrate method].
    Ujiie M; Kuroiwa K; Nagasawa T; Sato Y; Kitahara N
    Rinsho Byori; 1989 Apr; Spec No 81():208-13. PubMed ID: 2754807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Decreased endothelial antithrombogenic activity in disseminated intravascular coagulation].
    Tsukasato T; Maruyama Y; Maruyama I
    Rinsho Ketsueki; 1987 Dec; 28(12):2110-6. PubMed ID: 2968472
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurements of antithrombin III in solid tumor patients with and without hepatic metastases.
    Rubin RN; Kies MS; Posch JJ
    Thromb Res; 1980 May 1-15; 18(3-4):353-60. PubMed ID: 7414535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antithrombin III: the correlation structure-function in healthy people and in cirrhotic patients (author's transl)].
    Vicente JM; Díaz Cremades JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(5):544-53. PubMed ID: 368998
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors].
    Zurborn KH; Gram J; Rohwedder E; Bewig B; Bruhn HD
    Med Klin (Munich); 1989 Nov; 84(11):515-8. PubMed ID: 2593977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies on plasma antithrombin III using an antiserum prepared in our laboratories.
    Cucuianu M; Cristea A; Vonica A; Lascu I
    Med Interne; 1988; 26(3):191-7. PubMed ID: 3187359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.